<DOC>
	<DOCNO>NCT01761656</DOCNO>
	<brief_summary>The purpose study determine whether preoperative load dose atorvastatin prevent perioperative myocardial infarction angiography main adverse cardiac event 1 month operation stable angina , unstable angina acute non-ST-segment elevation myocardial infarction patient undergo elective coronary angiography PCI , determine whether mechanism associate microcirculation resistance .</brief_summary>
	<brief_title>Atorvastatin Reduction Myocardial Damage During Angiography Its Mechanism Associated With IMR</brief_title>
	<detailed_description>With 20 year popularity clinical application percutaneous coronary intervention ( PCI ) , increase attention pay postoperative myocardial injury ( MI ) PCI . NAPLES II1 ARMYDA2Studies show load dose statin therapy PCI ACS patient reduce perioperative myocardial infarction major adverse cardiac event ( MACE ) mortality 1 year PCI . The core mechanism effect statins clinical outcome above-mentioned , completely explain lipid-lowering effect , far discover previous study . Thus interest researcher turn point view , coronary microcirculation . MI PCI kind non-ST-segment elevation myocardial infarction ( NSTEMI ) relate coronary microcirculation , detect coronary angiography , detect index microcirculatory resistance ( IMR ) examination . In study , recruit stable angina , unstable angina acute non-ST-segment elevation myocardial infarction patient confirm coronary angiography . At time enrollment , patient randomly assign load dose group ( atorvastatin 80 mg 12 hour PCI 40 mg 2 hour PCI 20mg/d PCI ) control group ( atorvastatin 20 mg 12 hour PCI 20mg/d PCI ) . When PCI perform , index microvascular resistance ( IMR ) measure procedure . Periprocedural myocardial infarction define post-PCI cardiac biomarker . All patient follow adverse cardiac event 1 month .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Patients stable angina Patients unstable angina patient Patients acute non STsegment elevation myocardial infarction Patients willing accept need regular followup study Patients 1875 year age Patients sign informed consent form ST segment elevation acute myocardial infarction Emergency coronary angiography patient Patients abnormal liver function Heavily calcify , distortion coronary lesion LVEF &lt; 30 % patient eGFR &lt; 30ml/min/1.73 Square meter Liver disease history muscle disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>stable angina</keyword>
	<keyword>unstable angina</keyword>
	<keyword>acute non-ST-segment elevation myocardial infarction</keyword>
	<keyword>PCI</keyword>
	<keyword>perioperative myocardial infarction</keyword>
	<keyword>major adverse cardiac event</keyword>
</DOC>